Anti-viral Drugs for Castleman Disease

Multicentric Castleman disease (CD) is sometimes associated with the virus HHV-8. Doctors have had success in treating some patients with multicentric CD with drugs that kill this virus, such as ganciclovir, valganciclovir, and foscarnet.

Many patients with HIV infection are treated with anti-retroviral therapy to keep the HIV in check. But the effect of therapy for HIV on CD is not clear.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Lurain K, Yarchoan R, Uldrick TS. Treatment of Kaposi sarcoma herpes virus-associated multicentric Castleman disease. Cancer Sci. 2017;9 [Epub ahead of print].

National Cancer Institute. Physician Data Query (PDQ). AIDS-related lymphoma treatment. 10/02/2015. Accessed at:  on January 11, 2018.

National Cancer Institute. Castleman disease. Accessed at on January 10, 2018.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: B-cell lymphomas. v.7.2017. Accessed at  on January 11, 2018 . 

National Organization for Rare Disorders. Castleman disease. Accessed at on January 5, 2018.

van Rhee F, Greenway A, Stone K. Treatment of idiopathic Castleman disease. Hematol Oncol Clin North Am. 2018;32(1):89-106.

Last Revised: February 5, 2018

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.